Evidence map›Paper›PMID 29199989›Full record

ArticleActa crystallographica. Section F, Structural biology communications2017

Crystal structure of an anti-idiotype variable lymphocyte receptor.

Bernard C Collins, Hiro Nakahara, Sharmistha Acharya, Max D Cooper, Brantley R Herrin, Ian A Wilson

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bernard C CollinsDepartment of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Hiro NakaharaEmory Vaccine Center and Department of Pathology and Laboratory Medicine, Emory University, 1462 Clifton Road Northeast, Atlanta, GA 30322, USA.
Sharmistha AcharyaDepartment of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Max D CooperEmory Vaccine Center and Department of Pathology and Laboratory Medicine, Emory University, 1462 Clifton Road Northeast, Atlanta, GA 30322, USA.
Brantley R HerrinEmory Vaccine Center and Department of Pathology and Laboratory Medicine, Emory University, 1462 Clifton Road Northeast, Atlanta, GA 30322, USA.
Ian A WilsonDepartment of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Emory University · USScripps Research Institute · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Characterization of the Lamprey Adaptive Immune SystemR01AI072435 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Max Dale Cooper · 2007 to 2026
$8.1M
Overall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9M
Structural Basis of T Cell Receptor RecognitionR37AI042266 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WILSON, IAN A · 2003 to 2012
$5.8M
Structural basis of TLR and NLR recognition and signalingR01AI042266 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WILSON, IAN A · 1998 to 2017
$3.7M
Smart Anti-Glycan Reagents to Generate the Human Glycome Atlas-SupplementU01CA199882 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CUMMINGS, RICHARD D, MERNAUGH, RAYMOND L · 2015 to 2017
$2.0M
NCI NIH HHS U01 CA199882NCI NIH HHS U01CA199882NIAID NIH HHS R01 AI042266NIAID NIH HHS R01 AI072435NIAID NIH HHS R37 AI042266NIGMS NIH HHS P41 GM103393NIGMS NIH HHS P41GM103393NIGMS NIH HHS P41 GM103694NIGMS NIH HHS P41GM103694NIH HHS R01A1042266NIH HHS RO1A1072435
6 · The paper itself

Abstract

Variable lymphocyte receptors (VLRs), the leucine-rich repeat (LRR)-based antigen receptors of jawless fish, have great utility in a wide variety of biochemical and biological applications, similar to classical Ig-based antibodies. VLR-based reagents may be particularly useful when traditional antibodies are not available. An anti-idiotype lamprey VLR, VLR39, has previously been identified that recognizes the heavy-chain CDR3 of the B-cell receptor (BCR) of a leukemic clone from a patient with chronic lymphocytic leukemia (CLL). VLR39 was used successfully to track the re-emergence of this clone in the patient following chemotherapy. Here, the crystal structure of VLR39 is presented at 1.5 Å resolution and compared with those of other protein-specific VLRs. VLR39 adopts a curved solenoid fold and exhibits substantial structural similarity to other protein-binding VLRs. VLR39 has a short LRRCT loop that protrudes outwards away from the concave face and is similar to those of its protein-specific VLR counterparts. Analysis of the VLR39-BCR interaction by size-exclusion chromatography and biolayer interferometry using the scFv version of the BCR confirms that VLR39 recognizes the BCR Fv region. Such VLR-based reagents may be useful for identifying and monitoring leukemia in CLL patients and in other clinical diagnostic assays.

Indexed as

Chromatography, GelCrystallography, X-RayEpitopesHumansModels, MolecularProtein ConformationReceptors, AntigenReceptors, Antigen, B-CellRecombinant ProteinsEpitopesReceptors, AntigenReceptors, Antigen, B-CellRecombinant Proteinsantibodiesanti-idiotypeB-cell receptorscrystallographyimmunologyleucine-rich repeatsstructural biologyvariable lymphocyte receptors

Identifiers

PMID29199989
PMCPMC5713673
OpenAlexW2768293782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.